Founded in 2013, NEWEDGE Overseas is a rapidly growing, tech-enabled pharmaceutical company dedicated to making patient care affordable and accessible worldwide. With over nine years of experience, the company specializes in APIs, FDFs, excipients, and intermediates, trading more than 2000 APIs across 40+ countries and partnering with 500+ entities. Their strong commitment to clarity and consistency drives excellence in product development, contract manufacturing, and licensing opportunities. An in-house research team continuously monitors industry trends to update their portfolio and source hard-to-find APIs. With a robust supply chain and distribution network, NEWEDGE ensures timely, cost-effective delivery, tailored to clients' needs. Under founder Chetankumar Savaliya's visionary leadership, the company upholds ethical conduct and pursues innovation to advance global healthcare, while actively engaging in social responsibility initiatives.